StockData
LeonaBio, Inc. logo

LeonaBio, Inc. (LONA) stock

LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.02−0.44 (-17.89%)

Close on Nov 20, 2026Market cap $19.03MP/E –Yield –

LeonaBio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for LeonaBio

LeonaBio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More LeonaBio figures

See a number that looks wrong?